Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Greg Spendjian who wrote (658)	12/15/1997 9:13:00 PM
From: Mark Bartlett	Respond to of 14101

Greg, <<Dimethaid Research Files New Drug Application With FDA>> Yes - this is positive news. I know tha company has had a number of pre-submission meetings with the FDA, to ensure all the required data is provided - hopefully that will speed up the approval process. As you indicated though, it will be months before we get the answer. Perhaps in the interim, there will be a progress report about WF10 ... seems to me we should be hearing something soon about the phase 2b trials. I know at the AGM, they were talking about finalizing that data for submission to a peer reviewed journal ... that should be much further along by now. MB